Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Calithera Biosciences (CALA) shares
Learn how to easily invest in Calithera Biosciences shares.
Calithera Biosciences is a biotechnology business based in the US. Calithera Biosciences stocks (CALA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.92 – a decrease of 9.4% over the previous week. Calithera Biosciences employs 92 staff and has a trailing 12-month revenue of around $9.8 million.
How to buy shares in Calithera Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CALA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Calithera Biosciences?
- Has coronavirus impacted Calithera Biosciences shares?
- Calithera Biosciences shares summary
- Compare share dealing platforms
- Is Calithera Biosciences stock a buy or sell?
- Calithera Biosciences performance over time
- Calithera Biosciences's financials
- How volatile are Calithera Biosciences shares?
- Does Calithera Biosciences pay a dividend?
- Have Calithera Biosciences shares ever split?
- Other common questions
Calithera Biosciences stock price (NASDAQ:CALA)Use our graph to track the performance of CALA stocks over time.
Calithera Biosciences shares at a glance
|Latest market close||$0.41|
|52-week range||$0.39 - $3.34|
|50-day moving average||$0.73|
|200-day moving average||$1.76|
|Wall St. target price||$2.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.94|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Calithera Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Calithera Biosciences price performance over time
|1 week (2022-01-21)||-9.48%|
|1 month (2021-12-28)||-38.79%|
|3 months (2021-10-28)||-78.89%|
|6 months (2021-07-28)||-79.53%|
|1 year (2021-01-28)||-85.93%|
|2 years (2020-01-28)||-93.76%|
|3 years (2019-01-28)||4.08|
|5 years (2017-01-27)||4.6|
Calithera Biosciences financials
|Revenue TTM||$9.8 million|
|Gross profit TTM||$-71,015,000|
|Return on assets TTM||-35.62%|
|Return on equity TTM||-69.48%|
|Market capitalisation||$33 million|
TTM: trailing 12 months
Calithera Biosciences share dividends
We're not expecting Calithera Biosciences to pay a dividend over the next 12 months.
Have Calithera Biosciences's shares ever split?
Calithera Biosciences's shares were split on a 1:48 basis on 18 September 2014. So if you had owned 48 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Calithera Biosciences shares – just the quantity. However, indirectly, the new 4700% higher share price could have impacted the market appetite for Calithera Biosciences shares which in turn could have impacted Calithera Biosciences's share price.
Calithera Biosciences share price volatility
Over the last 12 months, Calithera Biosciences's shares have ranged in value from as little as $0.3901 up to $3.335. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Calithera Biosciences's is 1.5129. This would suggest that Calithera Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Calithera Biosciences overview
Calithera Biosciences, Inc. , a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate is CB-839, an inhibitor of glutaminase, which is in Phase II clinical trial to treat solid tumors. The company also offers INCB001158, an oral inhibitor of arginase that is in Phase I/II clinical trial for the treatment of hematology and oncology. The company is also developing CB-280, an oral arginase inhibitor that is in Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and CB-708, an orally administered small molecule inhibitor of CD73, as well as CB-668, an inhibitor of the enzyme IL4I1. It has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare.
Calithera Biosciences in the news
CALITHERA BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.